AH
BNTX icon

Andreas Halvorsen’s BioNTech BNTX Stock Holding History

Andreas Halvorsen’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-879,972
Closed -$80.1M – 86
2025
Q1 		$80.1M Sell
879,972
-60,878
-6% -$6.82M 0.25% 68
2024
Q4 		$107M Buy
940,850
+894,556
+1,932% +$102M 0.35% 62
2024
Q3 		$5.5M Buy
+46,294
New +$4.26M 0.02% 82

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Andreas Halvorsen's BNTX Position: Q2 2025 in Review

Andreas Halvorsen sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 879,972 shares — an estimated $80.1M sold.

Andreas Halvorsen first reported a position in BNTX in Q3 2024 and held it in 3 quarters. The position peaked at $107M in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Andreas Halvorsen reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Andreas Halvorsen sold 879,972 BioNTech shares in Q2 2025, an estimated $80.1M.
  • Andreas Halvorsen first reported a position in BioNTech in Q3 2024 and held it in 3 quarters.
  • Andreas Halvorsen's BioNTech position peaked at $107M in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Viking Global Investors's 13F filing for Q2 2025, filed 14 Aug 2025.